Trial intelligence / Profile preview

Mucosamin versus curcumin versus chlorhexidine for oral mucositis in cancer patients

IRCT20180316039112N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of curcumin and chlorhexidine in stomatitis (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Wound healing. Started Apr 2018; status: completed.

02

Drugs

curcuminchlorhexidine
03

Conditions

stomatitis

Beyond the preview

Go deeper on IRCT20180316039112N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180316039112N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call